Black Rose Industries (514183) — Analysis & Assessment

Analysis Date: 2026-08-06
Current Price: ₹112.2 | Market Cap: ₹572 Cr | Trailing P/E: 25.5x | P/B: 3.4x

1. Catalyst Evaluation & Freshness Check

• Announcement: Press release detailing Q1 FY27 financial performance (PAT up 146% YoY to ₹10.41 Cr, revenue up 48% YoY to ₹90.14 Cr, ₹2 interim dividend declared).
• Freshness / Already Priced In: TRUE. The core financial numbers (Q1 FY27 PAT ₹10.39-10.41 Cr, 48-49% YoY revenue growth, ₹2 interim dividend) were already disclosed to exchanges on 2026-07-31 (6 days prior). The stock price (+24.4% in 3m) reflects this operational turnaround.
• Key Disclosures in Press Release: EBITDA margin expanded to 17.33% (vs 11.5% YoY), driven by improved trading/distribution spreads as raw material (Acrylonitrile) dropped from $1,800/MT to $1,500/MT.

2. Industry Context & Quality Gate

• Quality Gate: PASSED. ROCE is strong at 19.0%, balance sheet is virtually debt-free (Debt ₹1 Cr, D/E 0.01), and promoter holding is capped at the maximum 75.0%.
• Capital Intensity: MEDIUM. While chemical manufacturing requires moderate capital, distribution is working-capital centric.
• Industry CAGR: Expected structural growth of ~12% for Indian specialty chemicals & distribution.

3. Financial Trend & Earnings Math

• Quarterly Momentum:
• Jun 2025 (Q1 FY26): Rev ₹59.85 Cr | PAT ₹4.19 Cr
• Sep 2025: Rev ₹83.98 Cr | PAT ₹4.43 Cr
• Dec 2025: Rev ₹75.15 Cr | PAT ₹4.40 Cr
• Mar 2026: Rev ₹104.04 Cr | PAT ₹9.41 Cr
• Jun 2026 (Q1 FY27): Rev ₹90.14 Cr | PAT ₹10.41 Cr
• EPS Run-Rate: Annualizing the last two quarters (PAT ~₹9.4 Cr & ₹10.4 Cr) indicates a run-rate PAT of ~₹38-40 Cr. Compared to FY26 PAT of ₹22.0 Cr (EPS ₹4.40), full-year FY27 EPS could reach ₹7.0 - ₹8.0, representing a ~60-80% EPS growth trajectory if raw material spreads do not sharply compress.

4. Valuation Context & Peer Comparison

• Trailing P/E of 25.5x vs Peer Median P/E of 17.9x.
• While trading at a premium to peer median, the forward P/E on FY27 annualized EPS (~₹7.5) drops to ~15.0x, which offers comfortable valuation cover.

5. Scenario Analysis & Valuation Targets

• Base Case (40% Upside to ₹157): FY27 EPS settles around ₹7.50 as distribution spreads normalize slightly. P/E recalibrates to 21x.
• Bull Case (85% Upside to ₹207): Acrylonitrile prices remain depressed while manufacturing volume scales up; FY27 EPS reaches ₹8.30 with a re-rating to 25x P/E.
• Bear Case (-28% Downside to ₹81): Acrylonitrile prices rebound sharply, compressing distribution spreads; quarterly PAT drops back to ~₹5 Cr (FY27 EPS ₹5.00), P/E de-rates to 16x.

6. Final Verdict Rationale

Black Rose exhibits strong fundamental quality (19% ROCE, zero net debt, 75% promoter holding) and significant operational momentum (Q1 PAT +146% YoY). However, because the announcement is a media release following up on earlier Q1 FY27 filings, the primary news event is already priced in near-term. The high share of distribution in recent growth introduces spread cyclicality. Hence, the stock is rated POSSIBLE for multibagger potential with a score of 62/100.